The report states Morepen Laboratories submitted an ANDA to the US FDA for Sitagliptin Tablets, its first such filing in the US.
Read this note →Morepen Laboratories Limited
NSE MOREPENLAB BSE 500288 INE083A01026
0 filings · 0 analysed
99.15
+116.89%
over 6 months
-
The report states Morepen Laboratories submitted an ANDA to the US FDA for Sitagliptin Tablets, its first such filing in the US.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
What the desks said
Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief